SEVILYA R BEZGINOVA

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Primary Care DULUTH, GA NPI 1124696703

General Payments — all program years on this page

$1,160.32

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 37
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $559.01 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $559.0114

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $487.9810
GENZYME CORPORATION $26.742
Grifols USA, LLC $22.431
Takeda Pharmaceuticals U.S.A., Inc. $21.861

By program year

Program yearAmountRecords
2023 $601.3123
2024 $559.0114

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104212627 AstraZeneca Pharmaceuticals LP $33.80 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104368945 AstraZeneca Pharmaceuticals LP $27.46 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104613460 AstraZeneca Pharmaceuticals LP $119.54 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104753212 AstraZeneca Pharmaceuticals LP $16.06 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105273462 AstraZeneca Pharmaceuticals LP $13.18 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105340137 AstraZeneca Pharmaceuticals LP $114.49 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105450629 AstraZeneca Pharmaceuticals LP $33.92 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105458807 AstraZeneca Pharmaceuticals LP $29.23 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105669217 AstraZeneca Pharmaceuticals LP $77.98 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105860936 AstraZeneca Pharmaceuticals LP $22.32 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124731255 Grifols USA, LLC $22.43 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137713973 Takeda Pharmaceuticals U.S.A., Inc. $21.86 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139964077 GENZYME CORPORATION $13.21 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139964093 GENZYME CORPORATION $13.53 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.